KSG IAS - KSG India (Official Telegram Channel)
15.8K subscribers
16.5K photos
287 videos
1.72K files
21.7K links
We welcome you all to KSG IAS. We are a well known UPSC Coaching Institute in India preparing candidates for the Civil Services Examination at all three stages of the exam such as Prelims, Mains and Interview. Call 9654376543 9990999707 For More Details.
Download Telegram
Today's Headlines - 08 August 2023
Centre to look into ‘Havana Syndrome’
GS Paper - 3 (Health and Diseases)

The Central government has told the Karnataka High Court that it will look into the matter of the ‘Havana Syndrome’ in India, in response to a Bengaluru resident’s recent petition. The petitioner had approached the court requesting a writ of mandamus for an enquiry on Havana Syndrome in India and the prevention of high-frequency microwave transmission in India.

What is Havana Syndrome?

Havana Syndrome refers to a set of mental health symptoms that are said to be experienced by United States intelligence and embassy officials in various countries.
It is worth noting that in general, the word ‘syndrome’ simply means a set of symptoms. It does not mean a unique medical condition, but rather a set of symptoms that are usually experienced together whose origins may be difficult to confirm.
What is known as the Havana Syndrome typically involves symptoms such as hearing certain sounds without any outside noise, nausea, vertigo and headaches, memory loss and balance issues.
As the name suggests, it traces its roots to Cuba in late 2016. This was about a year after the US opened its embassy in the capital city of Havana after ties between the two countries were normalised in 2015.
Some US intelligence officials and members of the staff at the embassy began experiencing sudden bursts of pressure in their brains followed by persistent headaches, feelings of disorientation and insomnia.

Where else has Havana syndrome been reported?

Since the Cuban incident, American intelligence and foreign affairs officials posted in various countries have reported symptoms of the syndrome.
In early 2018, similar accusations began to be made by US diplomats in China. The first such report was in April 2018 at the Guangzhou consulate.
An American employee reported that he had been experiencing symptoms since late 2017. Another incident had previously been reported by a USAID employee at the US Embassy in Tashkent, Uzbekistan, in September 2017.
In 2019 and 2020, such incidents have been reported from within the US — particularly in Washington DC. One incident was even reported at The Ellipse, a lawn adjacent to the White House.
In India, the first such case was reported in the same year, when a US intelligence officer travelling to New Delhi with CIA director William Burns reported symptoms of Havana Syndrome.

What are the causes of Havana Syndrome?

No one is entirely sure. But initially during the Cuban experience, being in a country that had been hostile to the US for over five decades, the suspicion was on Cuban intelligence or a section within the Cuban establishment that did not want US-Cuba relations to normalise. It was then speculated to be a “sonic attack”.
However, further study by scientists in the US and medical examination of the victims began to suggest that they may have been subjected to high-powered microwaves that either damaged or interfered with the nervous system.

#upsc #news #headline #health #diseases #havana #syndrome #karnataka #highcourt #india #bengaluru #mandamus #resident #transmission #symptoms #embassy #unique #medical #cuba #roots #US #guangzhou #consulate #washington #newdelhi #sonicattack #cuban #microwaves #nervous #system
Today's Headlines - 23 August 2023
Maternal vaccine to prevent RSV in infants
GS Paper - 3 (Health and Diseases)

The United States became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.

More about the Vaccine

The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from 32 through 36 weeks of pregnancy, to protect infants from birth through six months.
It is the latest in a succession of medicines recently approved against the common microbe, which causes tens of thousands of hospitalizations among infants and the elderly in the United States every year.
Researchers have targeted an RSV vaccine since the 1960s, but the spates of shots that are emerging now were made possible thanks to a scientific breakthrough a decade ago.
RSV is a common cause of illness in children and infants are among those at highest risk for severe disease, which can lead to hospitalization.
This approval provides an option for healthcare providers and pregnant individuals to protect infants from this potentially life-threatening disease.
The approval follows a clinical trial involving some 7,000 pregnant women, which showed Pfizer's vaccine, called Abrysvo, reduced severe disease caused by RSV by 82 percent in babies from 0-3 months, and 69 percent from 0-6 months.
Abrysvo was previously approved by the FDA for adults aged 60 and over, as was another vaccine by drugmaker GSK, called Arexvy.
While RSV most often causes mild, cold-like symptoms in infants and young children, it can also lead to more serious outcomes such as pneumonia and bronchiolitis.

#upsc #news #headline #maternal #vaccine #RSV #healthanddiseases #country #pregnantwomen #severedisease #respiratory #syncytical #virus #vaccine #protectinfacts #commonmicrbe #spatesofshots #illness #healthcare #disease #succession #scientific #hospitalizations #medicines #women #abrysvo #FDA #Arexvy #symptoms #pneumonia #bronchiolitis